Floatz logo

ISOSORBIDE DINITRATE

Atherosclerosis, Coronary

Ukrainian Medical Stomatological AcademySmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Atherosclerosis, Coronary cohort.

Asset / SponsorPhaseRating
Rosuvastatin
Ukrainian Medical Stomatological Academy
Phase 4BB
Bisoprolol Fumarate
Ukrainian Medical Stomatological Academy
Phase 4BB
Acetylsalicylic Acid
Ukrainian Medical Stomatological Academy
Phase 4BB
Pioglitazone
Ukrainian Medical Stomatological Academy
Phase 4BB
Ezetimibe
Samsung Medical Center
Phase 4BB
RAMIPRIL
Ukrainian Medical Stomatological Academy
Phase 4BB
Rimonabant
Sanofi
Phase 3CC
Edoxaban
Asan Medical Center
D

Same molecule, other indications

ISOSORBIDE DINITRATE is also rated in:

iatrogenicDormant
BB
Indicative ·
69 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
BB
Indicative ·
69 / 100
View asset →
Duchenne muscular dystrophyDormant
CC
Indicative ·
44 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →